Company profile: Tergus Pharma
1.1 - Company Overview
Company description
- Provider of end-to-end topical pharmaceutical research, drug development, testing, and manufacturing services as a CDMO, including contract R&D and commercial manufacturing for topical pharmaceuticals, plus cGMP-compliant testing services. Based in Durham, North Carolina.
Products and services
- CGMP Testing Services: Delivers cGMP-compliant testing for pharmaceutical products, ensuring adherence to current Good Manufacturing Practices across development and manufacturing stages
- Pharmaceutical Product Development Services: Architects end-to-end topical pharmaceutical research and drug development, integrating testing and manufacturing activities for coordinated advancement of topical therapeutic products
- Topical CDMO: Conducts contract R&D and commercial-scale manufacturing for topical pharmaceuticals, delivering research, development, and production services under CDMO engagements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tergus Pharma
Central Research Associates
HQ: United States
Website
- Description: Provider of multi-specialty clinical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Central Research Associates company profile →
Lightcast
HQ: United Kingdom
Website
- Description: Provider of a droplet-based microfluidics and oEWOD platform for parallel and sequential single-cell assays, live-cell recovery for downstream applications, and multi-step workflows that streamline lead identification and optimization in drug discovery, supporting basic and translational research on cell-to-cell communication, immune function, and the impact of CRISPR edits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightcast company profile →
Coldchain Tech
HQ: United States
Website
- Description: Provider of cold chain management solutions for temperature-sensitive products, including VIP Shipping Systems with customizable -40°C to +70°C control; Sentry Monitoring Technology for 24/7 real-time tracking and compliance; emergency preparedness logistics and packaging; reusable thermal shippers; end-to-end fulfillment services; and SHIP2Q for hygienic, sustainable transport with component reuse.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coldchain Tech company profile →
Remus Pharmaceuticals
HQ: United States
Website
- Description: Provider of sterile liquid injectables and oral solid forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remus Pharmaceuticals company profile →
START Research
HQ: United States
Website
- Description: Provider of oncology and biotechnology research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full START Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tergus Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tergus Pharma
2.2 - Growth funds investing in similar companies to Tergus Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tergus Pharma
4.2 - Public trading comparable groups for Tergus Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →